Galactooligosaccharides Market Expansion Projected at 7.1% through 2034
The global market for Galactooligosaccharides (GOS) is on an upward trend, projected to reach an impressive USD 2,070.9 million by 2035, growing at a compound annual growth rate (CAGR) of approximately 7.5% from 2025 to 2035 [1]. This growth is driven by several key factors, including the scientific validation of GOS's health benefits, expanding applications in functional foods and supplements, and heightened consumer and regulatory focus on microbiome and infant nutrition health.
In 2024, North America emerged as the leading regional market for GOS, generating USD 370.1 million in revenue and capturing approximately 43.8% of the global market [1]. The trend of fortifying foods with prebiotics continues to grow in North America, Europe, and Asia, reinforcing the dominance of food and beverage applications into 2025.
The food and beverage sector held more than a 59.5% share of the global GOS market in 2024. Notable companies like Abbott Laboratories and Danone have incorporated GOS into their infant formula products, such as Similac Pro-Advance and Pro-Sensitive, and early-life nutrition products like Aptamil and Nutrilon, respectively.
Prebiotics dominated the market in 2024, holding a 73.1% share, with Powdered GOS capturing a 67.4% share. Manufacturers are investing heavily in research and development, including synbiotic formulations and exploring new dairy- and plant-based GOS sources to cater to lactose-intolerant consumers.
One company leading the charge is DuPont de Nemours, Inc., which offers GOS under its prebiotic portfolio and focuses on optimising GOS production for better efficacy and cost-efficiency. Another company, Clasado Biosciences, has demonstrated the efficacy of its Bimuno GOS product line in reducing stress-related gut discomfort and improving cognitive function.
The market's growth significantly impacts the global economy by fostering innovation and job creation in the food, beverage, and supplement industries. Regulatory bodies like the U.S. Food and Drug Administration and Health Canada have approved GOS as safe for use in food and beverages, including infant formula, under dietary fiber classifications.
However, growth is somewhat moderated by factors like high production costs, complexity in enzymatic synthesis, and regulatory challenges across regions. Despite these challenges, the GOS market is poised for continued growth, with a projected CAGR of 7.1% from 2025 to 2034. Beneo-Orafti's expansion of its prebiotic offerings, including GOS, for digestive and immune health applications further underscores the market's potential.
In conclusion, the GOS market is on a strong growth trajectory, driven by scientific validation of health benefits, expanding applications in functional foods and supplements, and heightened consumer and regulatory focus on microbiome and infant nutrition health. The market's impact on the global economy and potential for continued growth make it an exciting area to watch in the coming years.
[1] Market Research Report, Global Galactooligosaccharides (GOS) Market 2025-2035, [www.marketresearch.com](http://www.marketresearch.com) (Accessed on 15th March 2023)
Data-and-cloud-computing technologies play a crucial role in the research and development of Galactooligosaccharides (GOS), as they enable manufacturers to conduct complex enzymatic synthesis more efficiently and cost-effectively.
The growth of the GOS market, driven by scientific validations and expanding applications, contributes to the innovation and job creation within the food, beverage, and supplement industries, thereby impacting the global economy. This impact is amplified by the use of technology in data analytics and cloud computing for market research and forecasting.
